WHO ICTRP trial
A single-center, open-label, randomized, single-dose, two-cycle, two-sequence…
ChiCTR2100054331 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100054331 |
|---|---|
| Public title | A single-center, open-label, randomized, single-dose, two-cycle, two-sequence, crossover bioequivalence study to evaluate the effects of the test preparation apremilast tablets and reference preparation apremilast tablets in healthy adult subjects in the fasting/postprandial state |
| Scientific title | A single-center, open-label, randomized, single-dose, two-cycle, two-sequence, crossover bioequivalence study to evaluate the effects of the test preparation apremilast tablets and reference preparation apremilast tablets in healthy adult subjects in the fasting/postprandial state |
| Primary sponsor | Huzhou Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Psoriasis |
| Interventions | Fasting group A (T-R):Take the test preparation first and then take the reference reagent;Fasting group B (R-T):Take the reference reagent first and then take the test preparation;Postprandial group A (T-R):Take the test preparation first… |
| Registration date | Dec 14, 2021 |
| Target size | Fasting group A (T-R):8;Fasting group B (R-T):8;Postprandial group A… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: